AAAAAA
Results: 1-25/38
Authors:
ADDE M
SHAD A
VENZON D
ARNDT C
GOOTENBERG J
NEELY J
NIEDER M
OWEN W
SEIBEL N
WILSON W
HORAK ID
MAGRATH I
Citation: M. Adde et al., ADDITIONAL CHEMOTHERAPY AGENTS IMPROVE TREATMENT OUTCOME FOR CHILDRENAND ADULTS WITH ADVANCED B-CELL LYMPHOMAS, Seminars in oncology, 25(2), 1998, pp. 33-39
Authors:
SHAD A
MUELLER B
ADDE M
AVILA N
SLEASMAN J
PIZZO P
MAGRATH I
Citation: A. Shad et al., RESULTS OF A TREATMENT PROTOCOL FOR CHILDREN WITH HIV AND NON-HODGKINS-LYMPHOMAS (NHLS), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 150-150
Authors:
VENKATESH H
MEZACORIA C
LOPEZCORELLA E
RIDAURASANZ C
OCONOR G
LUNA RR
BHATIA K
MAGRATH I
Citation: H. Venkatesh et al., EXPRESSION OF P53 IN PEDIATRIC LYMPHOMAS FROM MEXICO - RELATION TO HISTOLOGY AND IMMUNOPHENOTYPE, International journal of oncology, 11(3), 1997, pp. 477-480
Authors:
ADVANI S
PAI S
ADDE M
VAIDYA S
VATS T
NARESH K
KURKURE PA
NAIR CN
VENZON D
MAGRATH I
Citation: S. Advani et al., PRELIMINARY-REPORT OF AN INTENSIFIED, SHORT-DURATION CHEMOTHERAPY PROTOCOL FOR THE TREATMENT OF PEDIATRIC NON-HODGKINS-LYMPHOMA IN INDIA, Annals of oncology, 8(9), 1997, pp. 893-897
INTRACLONAL MOLECULAR HETEROGENEITY SUGGESTS A HIERARCHY OF PATHOGENETIC EVENTS IN BURKITTS-LYMPHOMA
Authors:
GUTIERREZ MI
BHATIA K
CHERNEY B
CAPELLO D
GAIDANO G
MAGRATH I
Citation: Mi. Gutierrez et al., INTRACLONAL MOLECULAR HETEROGENEITY SUGGESTS A HIERARCHY OF PATHOGENETIC EVENTS IN BURKITTS-LYMPHOMA, Annals of oncology, 8(10), 1997, pp. 987-994
Authors:
SHAD A
MAGRATH I
Citation: A. Shad et I. Magrath, NON-HODGKINS-LYMPHOMA, The Pediatric clinics of North America, 44(4), 1997, pp. 863
Authors:
MAGRATH I
Citation: I. Magrath, LIMITING THERAPY FOR LIMITED CHILDHOOD NON-HODGINS-LYMPHOMA, The New England journal of medicine, 337(18), 1997, pp. 1304-1306
EXPRESSION OF DEATH INDUCING GENES AND THE ACTIVATION OF DEATH INDUCING PATHWAY IN BURKITTS-LYMPHOMA
Authors:
GUTIERREZ MI
CHERNEY B
HUSSAIN A
MAGRATH I
BHATIA K
Citation: Mi. Gutierrez et al., EXPRESSION OF DEATH INDUCING GENES AND THE ACTIVATION OF DEATH INDUCING PATHWAY IN BURKITTS-LYMPHOMA, Blood, 90(10), 1997, pp. 335-335
INTRACLONAL MOLECULAR HETEROGENEITY SUGGESTS A HIERARCHY OF PATHOGENETIC EVENTS IN BURKITTS-LYMPHOMA
Authors:
GUTIERREZ MI
CAPELLO D
CHERNEY B
GAIDANO G
MAGRATH I
BHATIA K
Citation: Mi. Gutierrez et al., INTRACLONAL MOLECULAR HETEROGENEITY SUGGESTS A HIERARCHY OF PATHOGENETIC EVENTS IN BURKITTS-LYMPHOMA, Blood, 90(10), 1997, pp. 336-336
Authors:
SAZAWAL S
BHATIA K
GURBUXANI S
ARYA LS
RAINA V
VATS T
MAGRATH I
BHARGAVA M
Citation: S. Sazawal et al., SIGNIFICANCE OF IMMUNOGLOBULIN (IG) AND T-CELL RECEPTOR (TCR) GENE REARRANGEMENTS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN INDIA, Blood, 90(10), 1997, pp. 823-823
Authors:
MAGRATH I
ADDE M
SHAD A
VENZON D
SEIBEL N
NEELEY J
GOOTENBERG J
ARNDT C
NIEDER M
OWEN W
WILSON W
HORAK I
Citation: I. Magrath et al., RELATIVE EFFICACY OF G AND GM-CSFS IN AMELIORATING TOXICITY IN AN INTENSIVE TREATMENT PROTOCOL FOR ADVANCED, DIFFUSE B-CELL NHLS, PREDOMINANTLY SMALL NONCLEAVED CELL LYMPHOMAS, Blood, 90(10), 1997, pp. 847-847
Authors:
RAO CR
GUTIERREZ MI
HUSSAIN A
MAGRATH I
BHATIA K
Citation: Cr. Rao et al., CONSTITUTIVE EXPRESSION OF FAS-LIGAND IN B-CELL LYMPHOMAS, Blood, 90(10), 1997, pp. 1084-1084
Authors:
JUDDE JG
SPANGLER G
MAGRATH I
BHATIA K
Citation: Jg. Judde et al., USE OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-1 IN TARGETED THERAPY OF EBV-ASSOCIATED NEOPLASIA, Human gene therapy, 7(5), 1996, pp. 647-653
Authors:
KHALED HM
ELMAWLA NG
ELSAID A
HAMZA MR
GAAFAR R
ELATTAR I
ABURABIA A
MAGRATH I
Citation: Hm. Khaled et al., COMBINATION CHEMOTHERAPY FOR ADVANCED BILHARZIAL BLADDER-CARCINOMA, Annals of oncology, 7(7), 1996, pp. 751-754
Authors:
MAGRATH I
ADDE M
SHAD A
VENZON D
SEIBEL N
GOOTENBERG J
NEELY J
ARNDT C
NIEDER M
JAFFE E
WITTES RA
HORAK ID
Citation: I. Magrath et al., ADULTS AND CHILDREN WITH SMALL NON-CLEAVED-CELL LYMPHOMA HAVE A SIMILAR EXCELLENT OUTCOME WHEN TREATED WITH THE SAME CHEMOTHERAPY REGIMEN, Journal of clinical oncology, 14(3), 1996, pp. 925-934
Authors:
KINGMA DW
SHAD A
TSOKOS M
FEST T
OTSUKI T
FREKKO K
WERNER E
WERNER A
MAGRATH I
RAFFELD M
JAFFE ES
Citation: Dw. Kingma et al., EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED SMOOTH-MUSCLE TUMOR ARISING IN A POSTTRANSPLANT PATIENT TREATED SUCCESSFULLY FOR 2 PT-EBV-ASSOCIATED LARGE-CELL LYMPHOMAS - CASE-REPORT, The American journal of surgical pathology, 20(12), 1996, pp. 1511-1519
Authors:
GUTIERREZ MI
RAJ A
SPANGLER G
GUERRERO I
JUDDE JG
MAGRATH I
BHATIA K
Citation: Mi. Gutierrez et al., SEQUENCE VARIATIONS IN EBNA-1 SPECIFIC FOR B-CELL OR T-CELL LYMPHOMASMAY UNDERLIE THE PATHOGENETIC ROLE OF EBV IN LYMPHOMAGENESIS, Blood, 88(10), 1996, pp. 823-823
Authors:
KURKURE P
PAI S
VAIDYA S
KAPOOR G
NAIR C
GOPAL R
SAIKIA T
PARIKH P
PAI V
MAGRATH I
ADVANI S
Citation: P. Kurkure et al., IMPACT OF IMPROVED SUPPORTIVE CARE ON TREATMENT OUTCOME IN ACUTE LYMPHOBLASTIC-LEUKEMIA - AN INDIAN EXPERIENCE, European journal of cancer, 31A, 1995, pp. 1241-1241
Authors:
HAMDY N
BHATIA K
SHAKER H
KAMEL A
ELMAWLA NG
ABOUENEIN M
YASSIN D
ELSHARKAWY N
MAGRATH I
Citation: N. Hamdy et al., MOLECULAR EPIDEMIOLOGY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN EGYPT, Leukemia, 9(1), 1995, pp. 194-202
Authors:
MAGRATH I
Citation: I. Magrath, BONE-MARROW TRANSPLANTATION, Lancet, 346(8966), 1995, pp. 59-60
Authors:
MAGRATH I
Citation: I. Magrath, BONE-MARROW TRANSPLANTATION FOR LEUKEMIA - A LAME STALKING HORSE FOR USE OF HIGH-TECHNOLOGY MEDICAL-CARE, Lancet, 345(8950), 1995, pp. 601-602
Authors:
BHATIA K
FAN SJ
SPANGLER G
WEINTRAUB M
OCONNOR PM
JUDDE JG
MAGRATH I
Citation: K. Bhatia et al., A MUTANT P21 CYCLIN-DEPENDENT KINASE INHIBITOR ISOLATED FROM A BURKITTS-LYMPHOMA, Cancer research, 55(7), 1995, pp. 1431-1435
Authors:
ANWAR N
KINGMA DW
BLOCH AR
MOURAD M
RAFFELD M
FRANKLIN J
MAGRATH I
ELBOLKAINY N
JAFFE ES
Citation: N. Anwar et al., THE INVESTIGATION OF EPSTEIN-BARR VIRAL SEQUENCES IN 41 CASES OF BURKITTS-LYMPHOMA FROM EGYPT - EPIDEMIOLOGIC CORRELATIONS, Cancer, 76(7), 1995, pp. 1245-1252
Authors:
NARESH K
BHATIA K
VENKATESH H
SOMAN C
PAI S
ADVANI S
ADDE M
MAGRATH I
Citation: K. Naresh et al., THE MAJORITY OF PRIMARY LYMPHOBLASTIC LYMPHOMAS EXPRESS P53, Blood, 86(10), 1995, pp. 1349-1349
Authors:
VENKATESH C
BHATIA K
LOPEZCORELLA E
MESA C
RIVERALUNA R
OCONNOR G
MAGRATH I
Citation: C. Venkatesh et al., P53 EXPRESSION IN CHILDHOOD NON-HODGKINS-LYMPHOMA IN MEXICO IS MORE FREQUENT IN B-CELL NONLYMPHOBLASTIC LYMPHOMAS THAN IN LYMPHOBLASTIC LYMPHOMAS, Blood, 86(10), 1995, pp. 1362-1362